Contact Us

MEETING NEWS

Akeso Announced Enrollment of First Patient in Phase 3 Trial of Cadonilimab for Consolidation Therapy After Concurrent or Sequential Chemoradiotherapy in NSCLC

Feb 13, 2025

HONG KONG,Feb. 13,2025--Akeso,Inc. (9926. HK) ("Akeso" or the "Company") announced the recent completion of the first patient enrollment in the Phase 3 randomized,double-blind,mult

Hankyung.com introduces: CODIT Launches AI-Powered English Policy Dashboard to Help Global Companies Track Korean Regulatory Changes

Feb 13, 2025

New platform provides real-time updates on Korean legislation and policy shifts for government affairs and legal teams

Ricoh Releases "The Business Guide to Print Technologies" - A Data-Driven Analysis of Print's Role in the Modern Workplace

Feb 13, 2025

New whitepaper presents independent research on print performance,sustainability,and security,helping businesses optimise their workplace technology

CStone Announces Inclusion of Cejemly® (sugemalimab) as a First-Line Combination Therapy for NSCLC in ESMO Guideline

Feb 11, 2025

SUZHOU,China,Feb. 10,2025-- CStone Pharmaceuticals ("CStone",HKEX: 2616),an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies,today

Line Inspectors: Treading the Mountain, Crossing the Snow To Guarantee the Power Supply

Feb 11, 2025

SHIHEZI,China,Feb. 10,2025-- On February 4th,the seventh day of the first lunar month,the General Mountain inShihezi City was enveloped in boundless whiteness. Early in the morning,Zhang Lin and L&uum

Toys to Promote Well-being for the Elderly Designed by Chula Lecturers

Feb 11, 2025

BANGKOK,Feb. 10,2025-- AChulalecturer,Associate Professor Pornthep Lertthewasiri,has developed innovative "toys and home decorations for the elderly" to enhance their physical and mental wel

1 ... 88 89 90 91 92 93 94 ... 348